A recent study has shown that METTL16 expression in pancreatic cancers confers synthetic lethality to PARP inhibition, revealing a novel function of METTL16 in homologous recombination repair, which is important for maintaining genome stability.38 The gene discussed is METTL16; the disease is pancreatic neoplasm.